
|Articles|March 1, 2002
Genetic test may predict disease progression, development
Alameda, CA-Early indications are that the Ocugene glaucoma genetic test (InSite Vision, Alameda, CA) has the potential of becoming a useful tool in determining the likelihood of glaucoma development or progression in certain patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
2
Q&A: What’s in the glaucoma treatment pipeline?
3
Sneak peek: What’s ahead at the second International Glaucoma Symposium in Mainz, Germany
4
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
5



























